251 related articles for article (PubMed ID: 31672300)
1. Treatment of Aggressive Thyroid Cancer.
Huang J; Harris EJ; Lorch JH
Surg Pathol Clin; 2019 Dec; 12(4):943-950. PubMed ID: 31672300
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
[TBL] [Abstract][Full Text] [Related]
3. Lenvatinib: Role in thyroid cancer and other solid tumors.
Cabanillas ME; Habra MA
Cancer Treat Rev; 2016 Jan; 42():47-55. PubMed ID: 26678514
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI; Bischoff L; Ball D; Bernet V; Blomain E; Busaidy NL; Campbell M; Dickson P; Duh QY; Ehya H; Goldner WS; Guo T; Haymart M; Holt S; Hunt JP; Iagaru A; Kandeel F; Lamonica DM; Mandel S; Markovina S; McIver B; Raeburn CD; Rezaee R; Ridge JA; Roth MY; Scheri RP; Shah JP; Sipos JA; Sippel R; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Yeh M; Cassara CJ; Darlow S
J Natl Compr Canc Netw; 2022 Aug; 20(8):925-951. PubMed ID: 35948029
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of differentiated thyroid cancer].
Hubold C; Buchmann I; Lehnert H
Dtsch Med Wochenschr; 2011 Apr; 136(17):891-5. PubMed ID: 21523640
[No Abstract] [Full Text] [Related]
6. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pacini F; Castagna MG; Brilli L; Pentheroudakis G;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii110-9. PubMed ID: 22997443
[No Abstract] [Full Text] [Related]
7. Surgery in the context of kinase inhibitor therapy for locally invasive thyroid cancer.
Hartl DM; Guerlain J; Bresuskin I; Baudin E; Lamartina L; Hadoux J; Leboulleux S; Schlumberger M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):650-655. PubMed ID: 31582321
[TBL] [Abstract][Full Text] [Related]
8. The Treatment of Well-Differentiated Thyroid Carcinoma.
Paschke R; Lincke T; Müller SP; Kreissl MC; Dralle H; Fassnacht M
Dtsch Arztebl Int; 2015 Jun; 112(26):452-8. PubMed ID: 26205749
[TBL] [Abstract][Full Text] [Related]
9. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
10. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
[No Abstract] [Full Text] [Related]
11. Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
Sherman EJ; Dunn LA; Ho AL; Baxi SS; Ghossein RA; Fury MG; Haque S; Sima CS; Cullen G; Fagin JA; Pfister DG
Cancer; 2017 Nov; 123(21):4114-4121. PubMed ID: 28662274
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Tumors You Don't Want to Miss.
Wong KS; Barletta JA
Surg Pathol Clin; 2019 Dec; 12(4):901-919. PubMed ID: 31672297
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological and prognostic findings on 27 cases of medullary thyroid carcinoma.
Gabsi A; El Amine El Hadj O; Goucha A; Said G; Laabidi B; Gamoudi A
Tunis Med; 2017 Feb; 95(2):97-102. PubMed ID: 29424867
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapy in Thyroid Cancer: State of the Art.
Valerio L; Pieruzzi L; Giani C; Agate L; Bottici V; Lorusso L; Cappagli V; Puleo L; Matrone A; Viola D; Romei C; Ciampi R; Molinaro E; Elisei R
Clin Oncol (R Coll Radiol); 2017 May; 29(5):316-324. PubMed ID: 28318881
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic approach for mixed anaplastic carcinoma of the thyroid.
St Cyr JA; Shearen J; Delaney JP
Minn Med; 1985 Dec; 68(12):893, 895-6, 901. PubMed ID: 4088180
[No Abstract] [Full Text] [Related]
17. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory thyroid cancer.
Berdelou A; Lamartina L; Klain M; Leboulleux S; Schlumberger M
Endocr Relat Cancer; 2018 Apr; 25(4):R209-R223. PubMed ID: 29371330
[TBL] [Abstract][Full Text] [Related]
19. Consensus conference on well-differentiated thyroid cancer: a summary.
Pasieka JL; Rotstein LE
Can J Surg; 1993 Aug; 36(4):298-301. PubMed ID: 8370008
[TBL] [Abstract][Full Text] [Related]
20. Drug therapy alternatives in the treatment of thyroid cancer.
O'Doherty MJ; Coakley AJ
Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
